Autopsy report · NCT01932658
Autologous Hematopoietic Stem Cell Transplantation for Crohn's Disease Treatment
Cause of deathFunding or business
“patients insurance would not cover the cost of the study procedures”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Early Phase 1
- Sponsor
- University of California, Los Angeles
- Sponsor type
- University, hospital or other
- Conditions
- Crohn's Disease
- Interventions
- Hematopoietic stem cell transplantation
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Genes Mutation Pentalogy of Cantrell
“Physician's chose to not follow through with the study.” - Efficacy, Safety, Tolerability and Pharmacokinetics of SUN13837 to Treat Acute Stroke
“study was stopped for business/administrative reasons and not for patient safety concerns” - Early Intervention for Gestational Diabetes
“Insufficient funding for enrollment of patients. The invesitgators realized the study could not be performed.” - Efficacy and Safety Study of Toremifene Citrate for the Reduction in the Risk of New Bone Fracture Occurrences in Men With Prostate Cancer
“cost of conducting the study and increased burden on the clinical trial professionals make it impossible for us to proceed with the development of the drug.” - Effect of Eplerenone in Elderly Hypertensive Early Stage Chronic Kidney Disease (CKD) Patients
“We could not find patients who agreed to enrolled this clinical study.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.